Все публикации

Download this slideset on thrombosis in myeloproliferative neoplasms, including key risk factors, predictive scoring systems, and the role of JAK2 mutations. Learn how these factors inform clinical decision-making and evidence-based strategies for preventing and managing arterial and venous thrombotic events

Review this text module to gain expert insight into the complex mechanisms driving thrombosis in myeloproliferative neoplasms, including key risk factors, predictive scoring systems, and the role of JAK2 mutations. Learn how these factors inform clinical decision-making and evidence-based strategies for preventing and managing arterial and venous thrombotic events.

Expert commentary on the evolving role of antibody–drug conjugate use in patients with relapsed/refractory DLBCL, including answers to frequently asked questions from a live webinar audience of healthcare professionals with a focus on patient selection, clinical integration, management challenges, and future directions within an increasingly complex treatment landscape.

Experts answer your questions related to the program, “The Art of Therapeutic Balance: Innovations in Pancreatic Cancer Across the Disease Continuum.” This social media forum provides you with ongoing access to experts for your questions and challenging cases throughout the certified life of this program.

The PDF/downloadable resource is intended to be used by healthcare providers and their eligible patients to highlight and communicate the reasons for recommending low-dose CT screening to detect lung cancer.

Download slides from a live webinar to gain global expert perspectives on molecular testing and perioperative immunotherapy and targeted therapy for early-stage NSCLC.

Experts answer your questions related to the program, “The Next Frontier for CDK4/6 Inhibitors in Breast Cancer: Expert Strategies for Applying the Latest Guidelines and Advances in Practice.” This social media forum provides you with ongoing access to experts for your questions and challenging cases throughout the certified life of this program.

Read this commentary detailing the results of a survey of healthcare professionals on managing patients with essential thrombocythemia (ET) and polycythemia vera (PV). Then review the expert-authored text modules, podcasts, and downloadable resources to close these gaps and improve patient outcomes.

Background Results Conclusions